NCT04019041 A Study to Evaluate the Efficacy, Safety and Tolerability of Bermekimab in Patients With Hidradenitis Suppurativa Status COMPLETED Phase PHASE2
NCT04018599 Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS Status COMPLETED Phase PHASE1
NCT03972280 Safety and Pharmacokinetics of Repeat Doses of CSL324 in Subjects With Hidradenitis Suppurativa and Palmoplantar Pustulosis Status COMPLETED Phase PHASE1
NCT03967600 Clinical and Biological Characteristics of Hidradenitis Suppurativa Status RECRUITING Phase N/A
NCT03960268 Biomarkers In Hidradenitis Suppurativa Participants Receiving Brodalumab Status COMPLETED Phase EARLY_PHASE1
NCT03929835 Study to Investigate the Efficacy and Safety of Cannabis Oil for the Treatment of Subjects With Hidradenitis Suppurativa Status WITHDRAWN Phase PHASE2
NCT03926169 A Global Study Comparing Risankizumab to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Status COMPLETED Phase PHASE2
NCT03852472 Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA) Status COMPLETED Phase PHASE2
NCT03827798 Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis Suppurativa Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03713632 Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS) Status COMPLETED Phase PHASE3
NCT03713619 This Was a Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS). Status COMPLETED Phase PHASE3
NCT03683238 Nutritional Status and Hidradenitis Suppurativa (Acne Inversa) Status COMPLETED Phase N/A
NCT03668925 Association Between Hidradenitis Suppurativa and Spondyloarthritis Status COMPLETED Phase NA
NCT03661866 A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03628924 A Study to Evaluate the Efficacy, Safety, and Tolerability of Guselkumab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa (HS) Status COMPLETED Phase PHASE2
NCT03607487 A Placebo-Controlled Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa Status COMPLETED Phase PHASE2
NCT03569371 A Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa Status COMPLETED Phase PHASE2